0
Renpho
Home Tags Exclusive

Tag: exclusive

Dr Nir Barzilai, Professor of Medicine and Genetics, predicts that rapamycin could decrease severity of coronavirus (COVID-19) in the elderly by 50%.
Features

COVID-19: Leading clinician calls for focus on the biology of aging

Danny Sullivan - 0
Investment

SyndicateRoom co-founder joins First Longevity

Danny Sullivan - 0
Investment

Longevity investment: Apollo aims for the moon

Danny Sullivan - 0
Biotech

Leading academic “profoundly disappointed” by COVID-19 response

Danny Sullivan - 0
Biotech

Exclusive interview: Professor Richard Faragher and cellular senescence

Danny Sullivan - 0
Axolotl’s Biosciences lead product, called ThinkInk, is a novel versatile bio-ink for bioprinting stem cell-derived neural tissues.
Innovation

New 3D bio-ink start-up targets neural tissue

Danny Sullivan - 0
The Forever Healthy Foundation published its latest analysis, focused on the use of dasatinib in conjunction with quercetin as a senolytic therapy.
Longevity TV

Video interview with Dr Isabelle Schiffer on senolytic safety

Danny Sullivan - 0
Braincures raising funds to target drug discovery for Alzheimer’s and other neurological diseases with data analysis and systems biological intelligence.
AI/Digital

Move over AI? Here comes biological intelligence

Danny Sullivan - 0
Marine biologist Dr Michèle Barbier is executive director at the Institute for Science & Ethics, which works to bring an ethical dimension to ocean science.
Biotech

Unlocking the Longevity potential of our oceans

Danny Sullivan - 0
Longevity AI
AI/Digital

Fountain’s ‘hypothesis-free’ approach to Longevity AI

Danny Sullivan - 0
123...8Page 1 of 8

LATEST ARTICLES

Sheekey Science
Longevity TV

The Sheekey Science Show: NAD+ rejuvenation strategies

Phil Newman - 0
NAD+ metabolism in aging & three strategies to rejuvenate. Welcome to The Sheekey Science Show! Longevity.Technology is delighted to partner with YouTube sensation Eleanor Sheekey (interviewed...
Juvicell

JUVICELL sets sights on lifespan and healthspan

Elevant

New NAD+ boosting longevity supplement hits the market

BioAge clinical trial

BioAge kicks off Phase 2 longevity clinical trial

Editor's picks

Popular posts

© Copyright 2021 PERGALI Limited. All rights reserved. PERGALI